Metabolic profiling of alcohol consumption in 9778 young adults

International Journal of Epidemiology

Volumn 45, Issue 5, 2016, Pages 1493-1506

  Würtz, Peter ^a   Cook, Sarah ^b   Wang, Qin ^a,c   Tiainen, Mika ^a,c   Tynkkynen, Tuulia ^a,c   Kangas, Antti J ^a   Soininen, Pasi ^a,c   Laitinen, Jaana ^d   Viikari, Jorma ^e   Kahönen, Mika ^f   Lehtimaki, Terho ^f   Perola, Markus ^g,h,i   Blankenberg, Stefan ^e,j,k   Zeller, Tanja ^j,k   Mannistö, Satu ^g   Salomaa, Veikko ^g   Jarvelin, Marjo Riitta ^a,l   Raitakari, Olli T ^e,m   Ala Korpela, Mika ^a,c,n   Leon, David A ^b,o  

^a UNIVERSITY OF OULU   (Finland)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ UNIVERSITY OF TARTU   (Estonia)

^j UNIVERSITY HEART CENTER HAMBURG   (Germany)

^k German Center for Cardiovascular Research   (Germany)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF TURKU   (Finland)

ⁿ UNIVERSITY OF BRISTOL   (United Kingdom)

^o UNIVERSITY OF TROMSØ   (Norway)

more..

Author keywords

Alcohol; Fatty acids; Metabolic profiling; Metabolomics; Risk factors

Indexed keywords

ALCOHOL; CITRIC ACID; GLUCOSE; GLUTAMINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; AMINO ACID; BIOLOGICAL MARKER; FATTY ACID; LIPOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FATTY ACID BLOOD LEVEL; FEMALE; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT; BLOOD; DRINKING BEHAVIOR; META ANALYSIS; METABOLISM; METABOLOME; RISK FACTOR; STATISTICAL MODEL;

ADULT; ALCOHOL DRINKING; AMINO ACIDS; BIOMARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FATTY ACIDS; FEMALE; FINLAND; HUMANS; LINEAR MODELS; LIPOPROTEINS; MALE; METABOLOME; METABOLOMICS; RISK FACTORS;

EID: 84997501050     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyw175     Document Type: Article

References (43)

1. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287–323.
2. World Health Organization. Global Status Report on Alcohol a Health 2014. Geneva: WHO, 2014.
3. O’Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol 2007;50:1009–14.
4. Bergmann MM, Rehm J, Klipstein-Grobusch K et al. The association of pattern of lifetime alcohol use and cause of death in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol 2014;42:1772–90.
5. Holmes MV, Dale CE, Zuccolo L et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014;349:g4164.
6. Gepner Y, Golan R, Harman-Boehm I et al. Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes. Ann Intern Med 2015;163:569–79.
7. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011;342:d636.
8. Taylor AE, Lu F, Carslake D et al. Exploring causal associations of alcohol with cardiovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis. Sci Rep 2015;5:14005.
9. Cho Y, Shin S-Y, Won S, Relton CL, Davey Smith G, Shin M-J. Alcohol intake and cardiovascular risk factors: A Mendelian randomisation study. Sci Rep 2015;5:18422.
10. Schwartz GG, Olsson AG, Abt M et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089–99.
11. Voight BF, Peloso GM, Orho-Melander M et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380:572–80.
12. Sabater-Lleal M, Huang J, Chasman D et al. Multiethnic meta-analysis of genome-wide association studies in > 100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation 2013;128:1310–24.
13. Yaghootkar H, Lamina C, Scott R et al. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes 2013;62:3589–98.
14. Zheng Y, Yu B, Alexander D, Steffen LM, Nettleton JA, Boerwinkle E. Metabolomic patterns and alcohol consumption in African Americans in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2014;99:1470–78.
15. Jaremek M, Yu Z, Mangino M et al. Alcohol-induced metabolomic differences in humans. Transl Psychiatry 2013;3:e276.
16. Harada S, Takebayashi T, Kurihara A et al. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men. Environ Health Prev Med 2016;21:18–26.
17. Mukamal KJ, Mackey RH, Kuller LH et al. Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 2007;92:2559–66.
18. Würtz P, Havulinna AS, Soininen P et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation 2015;131:774–85.
19. Fischer K, Kettunen J, Würtz P et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: An observational study of 17,345 persons. PLoS Med 2014;11:e1001606.
20. Mahendran Y, Cederberg H, Vangipurapu J et al. Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men. Diabetes Care 2013;36:3732–38.
21. Stancakova A, Civelek M, Saleem NK et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 2012;61:1895–902.
22. Würtz P, Raiko JR, Magnussen CG et al. High-throughput quantification of circulating metabolites improves prediction of sub-clinical atherosclerosis. Eur Heart J 2012;33:2307–16.
23. J€arvelin M-R, Sovio U, King V et al. Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension 2004;44:838–46.
24. Würtz P, Wang Q, Kangas AJ et al. Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change. PLoS Med 2014;11:e1001765.
25. Vartiainen E, Laatikainen T, Peltonen M et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010;39:504–18.
26. Juonala M, Viikari JSA, K€ahönen M et al. Alcohol consumption is directly associated with carotid intima–media thickness in Finnish young adults. Atherosclerosis 2009;204:e93–e98.
27. Poikolainen K, Vartiainen E. Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee. Am J Epidemiol 1997;146:1019–24.
28. Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet 2015;8:192–206.
29. Kujala UM, M€akinen V-P, Heinonen I et al. Long-term leisure-time physical activity and serum metabolome. Circulation 2013;127:340–48.
30. Soininen P, Kangas AJ, Würtz P et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009;134:1781.
31. Kettunen J, Demirkan A, Würtz P et al. Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. Nat Commun 2016;7:11122.
32. Brinton EA. Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep 24;4:108–14.
33. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009;119:931–39.
34. Do R, Willer CJ, Schmidt EM et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013;45:1345–52.
35. Whitfield JB, Heath AC, Madden PAF, Pergadia ML, Montgomery GW, Martin NG. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcoholism Clin Exp Res 2013;37:575–86.
36. Tolstrup JS, Gronbaek M, Nordestgaard BG. Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol de-hydrogenase genotypes. Circ Cardiovasc Genet 2009;2:507–14.
37. Wu JHY, Lemaitre RN, King IB et al. Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study. Circulation 2014;130:1245–53.
38. Simon JA, Fong J, Bernert JT, Browner WS. Relation of smoking and alcohol consumption to serum fatty acids. Am J Epidemiol 1996;144:325–34.
39. Teubert A, Thome J, Büttner A, Richter J, Irmisch G. Elevated oleic acid serum concentrations in patients suffering from alcohol dependence. J Mol Psychiatry 2013;1:13.
40. Cheng S, Rhee EP, Larson MG, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 2012;125:2222–2231.
41. Roberts LD, Gerszten RE. Toward new biomarkers of cardiometabolic diseases. Cell Metab 2013;18:43–50.
42. Wise DR, Ward PS, Shay JES et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of a-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 2011;108:19611–16.
43. Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 2013;123:3678–3684.